| 000 | 01501 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250512023113.0 | ||
| 264 | 0 | _c19860715 | |
| 008 | 198607s 0 0 eng d | ||
| 022 | _a0306-5251 | ||
| 024 | 7 |
_a10.1111/j.1365-2125.1986.tb02848.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAlabaster, V A | |
| 245 | 0 | 0 |
_aThe alpha 1-adrenoceptor antagonist profile of doxazosin: preclinical pharmacology. _h[electronic resource] |
| 260 |
_bBritish journal of clinical pharmacology _c1986 |
||
| 300 |
_a9S-17S p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdrenergic alpha-Antagonists |
| 650 | 0 | 4 | _aAnesthesia |
| 650 | 0 | 4 |
_aAngiotensin II _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xpharmacology |
| 650 | 0 | 4 | _aCats |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 | _aDoxazosin |
| 650 | 0 | 4 | _aElectric Stimulation |
| 650 | 0 | 4 |
_aHeart _xdrug effects |
| 650 | 0 | 4 |
_aHypertension, Renal _xdrug therapy |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMuscle Contraction _xdrug effects |
| 650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xdrug effects |
| 650 | 0 | 4 |
_aNictitating Membrane _xdrug effects |
| 650 | 0 | 4 |
_aPrazosin _xanalogs & derivatives |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 | _aSpecies Specificity |
| 700 | 1 | _aDavey, M J | |
| 773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 21 Suppl 1 _gp. 9S-17S |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2125.1986.tb02848.x _zAvailable from publisher's website |
| 999 |
_c2877702 _d2877702 |
||